ViewRay up 2% after hours on MRIdian sale to Stanford Health Care

|About: ViewRay, Inc. (VRAY)|By:, SA News Editor

ViewRay (NASDAQ:VRAY) announces that Stanford, CA-based Stanford Health Care will acquire a MRIidian radiotherapy device, apparently under a collaboration agreement, although it does provide the details of said agreement.

It appears that Stanford will not be purchasing the system, at least not initially, but will conduct collaborative studies of some sort.

Shares up 2% after hours.

Subscribe for full text news in your inbox